Tomorrow at MESC Conference 2015, we will be presenting the success of Mississippi DOM’s Medicaid Clinical Provider Portal with the Mississippi Division of Medicaid. If you’re attending come see us at 9:30 a.m. ET in Room 319.
The session will cover how the Mississippi Division of Medicaid (DOM) deployed Provider Access, a clinical portal that gives Medicaid physicians real-time access to a single source of clinical data from multiple health systems on DOM beneficiaries. Medicaid providers now have insight into a patient’s longitudinal health record for all DOM beneficiaries with the ability to export Medicaid clinical data from the portal directly into their EMRs (a Meaningful Use Stage 2 requirement). This clinical portal leverages DOM’s EMPI—a critical component as DOM moves toward MITA 3.0—that manages over 2.3 million potential beneficiaries’ identities.
Chris Smith, clinical data interoperability program manager at Mississippi DOM, will discuss this innovative project including, the core elements of the clinical portal fostering population health and interoperability, the challenges surmounted in the face of this new program along with funding, adoption rates, capabilities and results—a year after implementation.
For the complete conference agenda and additional details on MESC Conference 2015, visit here.
Get our take on industry trends
MedeAnalytics at HIMSS26: Turning Insight into Measurable Healthcare Performance
March 9-12, 2026 | Venetian Convention & Expo Center | Las Vegas As margin pressure intensifies and value-based care…
Read on...Turning social risk into measurable financial performance
Payers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many…
Read on...The GLP-1 Insights Series, Part 2: Maximizing impact and savings through analytics
GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers…
Read on...The GLP-1 Insights Series, Part 1: Long-term impact on costs and outcomes for payers and providers
Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally…
Read on...